Researchers from the Gwangju Institute of Science and Technology have developed a deep learning model that predicts unexpected drug-drug interactions (DDIs) based on their effects on gene expression.
We are at a transformational period in oncology; the overall mortality from cancer is gradually declining in the United States.
